XML 32 R22.htm IDEA: XBRL DOCUMENT
v3.26.1

Revenue Recognition (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Revenue from Contract with Customer [Abstract] |
Disaggregation of Revenue [Table Text Block] |
Three months ended March 31, 2026 | U.S. Operations |  | Swiss Operations |  | Western European Operations |  | Chinese Operations |  | Other Operations |  | Total
Product Revenue | $ | 239,958 |  |  | $ | 38,375 |  |  | $ | 139,730 |  |  | $ | 140,053 |  |  | $ | 126,138 |  |  | $ | 684,254 |
Service Revenue: |  |  |  |  |  |  |  |  |  |  |
Point in time | 80,198 |  |  | 8,952 |  |  | 48,068 |  |  | 8,613 |  |  | 37,001 |  |  | 182,832 |
Over time | 28,391 |  |  | 3,432 |  |  | 27,585 |  |  | 4,857 |  |  | 15,776 |  |  | 80,041 |
Total | $ | 348,547 |  |  | $ | 50,759 |  |  | $ | 215,383 |  |  | $ | 153,523 |  |  | $ | 178,915 |  |  | $ | 947,127 |
Three months ended March 31, 2025 | U.S. Operations |  | Swiss Operations |  | Western European Operations |  | Chinese Operations |  | Other Operations |  | Total
Product Revenue | $ | 247,067 |  |  | $ | 36,298 |  |  | $ | 124,850 |  |  | $ | 128,197 |  |  | $ | 113,538 |  |  | $ | 649,950 |
Service Revenue: |  |  |  |  |  |  |  |  |  |  |
Point in time | 73,330 |  |  | 8,248 |  |  | 42,476 |  |  | 8,822 |  |  | 29,915 |  |  | 162,791 |
Over time | 25,361 |  |  | 2,756 |  |  | 23,043 |  |  | 4,149 |  |  | 15,694 |  |  | 71,003 |
Total | $ | 345,758 |  |  | $ | 47,302 |  |  | $ | 190,369 |  |  | $ | 141,168 |  |  | $ | 159,147 |  |  | $ | 883,744 |
A breakdown of net sales to external customers by geographic customer destination for the three months ended March 31 follows:
| 2026 |  | 2025
Americas | $ | 389,339 |  |  | $ | 377,916 |
Europe | 278,686 |  |  | 247,975 |
Asia / Rest of World | 279,102 |  |  | 257,853 |
Total | $ | 947,127 |  |  | $ | 883,744 |
The Company's global revenue mix by product category is laboratory (55% of sales), industrial (40% of sales) and retail (5% of sales). The Company's product revenue by reportable segment is proportionately similar to the Company's global revenue mix except the Company's Swiss Operations is largely comprised of la boratory products, while the Company's Chinese Operations has a slightly higher percentage of industrial products. A breakdown of the Company’s sales by product category for the three months ended March 31 fo llows:
| 2026 |  | 2025
Laboratory | $ | 524,581 |  |  | $ | 500,224 |
Industrial | 374,640 |  |  | 341,200 |
Retail | 47,906 |  |  | 42,320 |
Total | $ | 947,127 |  |  | $ | 883,744 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration